Breast Cancer Research
Edited by David Miles
Collection published: 20 September 2001
Last updated: 11 October 2001
Review
Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
David W Miles Breast Cancer Res 2001, 3:380-384 (11 October 2001)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
Intracellular signaling pathways of ErbB2/HER-2 and family members
Monilola A Olayioye Breast Cancer Res 2001, 3:385-389 (4 October 2001)
Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer
William J Gullick Breast Cancer Res 2001, 3:390-394 (1 October 2001)
Abstract | Full text | PDF | PubMed
Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment
Helen C Hurst Breast Cancer Res 2001, 3:395-398 (1 October 2001)
Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition
Isabel Correa, Tim Plunkett Breast Cancer Res 2001, 3:399-403 (20 September 2001)
